Media Releases

AFTINET disappointed at Senate majority approval of TPP-11

Media Release 17 October 2018: “AFTINET is deeply disappointed that the Senate looks set to pass the TPP-11 implementing legislation,” AFTINET Convener Dr Patricia Ranald said today.

“Progressive civil society groups, including public health, environment, aid and development groups, churches and unions have played a leading role in exposing the dangers of the TPP-11 in what has been an eight-year public debate.”

AFTINET remains opposed to the TPP-11 but welcomes ALP Bill for fairer future trade deals

15 October 2018: “AFTINET welcome the pledges for progressive changes to future trade policy in shadow Trade Minister Jason Clare’s Bill  announced today, as the TPP-11 implementing legislation is being debated by the Senate. However we remain opposed to theTPP-11 because it restricts the right of future governments to regulate in the public interest.

Community groups disappointed that Senate TPP-11 Report identifies serious flaws but endorses TPP-11 implementation

Media Release - September 18, 2018     
“We are deeply disappointed that the Labor majority report of the Senate Standing Committee on the TPP-11 has strongly criticized many aspects of the deal and recommended changes by a future government,  but has nevertheless endorsed its implementation,” AFTINET Convener Dr Patricia Ranald said today.

JSCOT report backs TPP-11, Labor critical but community groups call for the Senate to say no

Media Release, August 22, 2018

“The report of the Government-dominated Joint Standing Committee on Treaties has predictably recommended the endorsement of the TPP-11 implementing legislation,” AFTINET Convener Dr Patricia Ranald said today.

“However, ALP committee members made the following critical comments: (pp 85-95)

Government should reject Trump’s threat to affordable medicines through TPP and other trade deals

Media Release, May 14, 2018: “US President Donald Trump’s policy to end “freeloading” and force trading partners to increase prices they pay for US pharmaceutical exports is a direct threat to Australia’s policy of ensuring affordable medicines through our Pharmaceutical Benefits Scheme,” AFTINET Convener Dr Patricia Ranald said today.

“This policy results from the US pharmaceutical companies absurd and unproven argument that if other governments abandon their affordable medicine policies and agree to higher prices, the companies would then lower their prices in the US. Both Canada and New Zealand have strongly rejected this push. There has so far been no reported response from the Turnbull government. We call on the government to reject this policy,” said Dr Ranald.

Trump backflip on the TPP exposes its problems: full parliamentary scrutiny needed

Media Release, April 13: "US President Trump’s announcement that he will renegotiate what is now the TPP-11 exposes the dodgy nature of the deal. The remaining 11 countries reached agreement on the basis that bad provisions sponsored by the US are identified as unacceptable but are only suspended and remain in the deal, and could be reactivated if the US re-joined,” AFTINET Convener Dr Patricia Ranald said today.

TPP-11: Government attempt to cut short inquiries would prevent democratic scrutiny, says AFTINET

Media release April 4, 2018: AFTINET Convener Dr Patricia Ranald today called on the government not to cut short parliamentary inquiries which are intended to scrutinise the revised TPP-11 (renamed the Progressive Comprehensive TPP) before Parliament votes on the implementing legislation.

Pages